Literature DB >> 22740699

Tyrosine residues mediate fibril formation in a dynamic light chain dimer interface.

Ara Celi DiCostanzo1, James R Thompson, Francis C Peterson, Brian F Volkman, Marina Ramirez-Alvarado.   

Abstract

Light chain amyloidosis is an incurable protein misfolding disease where monoclonal immunoglobulin light chains misfold and deposit as amyloid fibrils, causing organ failure and death. Previously, we determined that amyloidogenic light chains AL-09 and AL-103 do not form fibrils at pH 10 (tyrosine pK(a)). There are three tyrosine residues (32, 91, and 96) clustered in the dimer interface, interacting differently in the two light chain proteins due to their two different dimer conformations. These tyrosines may be ionized at pH 10, causing repulsion and inhibiting fibril formation. Here, we characterize single and double Tyr-to-Phe mutations in AL-09 and AL-103. All AL-09 Tyr-to-Phe mutants form fibrils at pH 10, whereas none of the AL-103 mutants form fibrils at pH 10. NMR studies suggest that although both AL-09 and AL-103 present conformational heterogeneity, only AL-09 favors dimer conformations where tyrosine residues mediate crucial interactions for amyloid formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22740699      PMCID: PMC3431636          DOI: 10.1074/jbc.M112.362921

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Comparison of amyloid fibril formation by two closely related immunoglobulin light chain variable domains.

Authors:  Douglas J Martin; Marina Ramirez-Alvarado
Journal:  Amyloid       Date:  2010-09       Impact factor: 7.141

2.  The effect of membranes on the in vitro fibrillation of an amyloidogenic light-chain variable-domain SMA.

Authors:  Xiaoyun Meng; Anthony L Fink; Vladimir N Uversky
Journal:  J Mol Biol       Date:  2008-06-28       Impact factor: 5.469

3.  Structural insights into the role of mutations in amyloidogenesis.

Authors:  Elizabeth M Baden; Edward G Randles; Awo K Aboagye; James R Thompson; Marina Ramirez-Alvarado
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

4.  Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score.

Authors:  Shaji K Kumar; Morie A Gertz; Martha Q Lacy; David Dingli; Suzanne R Hayman; Francis K Buadi; Kristen Short-Detweiler; Steven R Zeldenrust; Nelson Leung; Philip R Greipp; John A Lust; Stephen J Russell; Robert A Kyle; S Vincent Rajkumar; Angela Dispenzieri
Journal:  Mayo Clin Proc       Date:  2011-01       Impact factor: 7.616

5.  A single mutation promotes amyloidogenicity through a highly promiscuous dimer interface.

Authors:  Francis C Peterson; Elizabeth M Baden; Barbara A L Owen; Brian F Volkman; Marina Ramirez-Alvarado
Journal:  Structure       Date:  2010-05-12       Impact factor: 5.006

6.  Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway.

Authors:  Jianru Shi; Jian Guan; Bingbing Jiang; Daniel A Brenner; Federica Del Monte; Jennifer E Ward; Lawreen H Connors; Douglas B Sawyer; Marc J Semigran; Thomas E Macgillivray; David C Seldin; Rodney Falk; Ronglih Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-11       Impact factor: 11.205

7.  Light chain amyloidosis - current findings and future prospects.

Authors:  Elizabeth M Baden; Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

8.  Structural alterations within native amyloidogenic immunoglobulin light chains.

Authors:  Edward G Randles; James R Thompson; Douglas J Martin; Marina Ramirez-Alvarado
Journal:  J Mol Biol       Date:  2009-04-08       Impact factor: 5.469

9.  Effect of methionine oxidation on the structural properties, conformational stability, and aggregation of immunoglobulin light chain LEN.

Authors:  Dongmei Hu; Zhijie Qin; Bin Xue; Anthony L Fink; Vladimir N Uversky
Journal:  Biochemistry       Date:  2008-07-25       Impact factor: 3.162

10.  Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture.

Authors:  L A Sikkink; M Ramirez-Alvarado
Journal:  Cell Death Dis       Date:  2010-11-11       Impact factor: 8.469

View more
  15 in total

1.  Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.

Authors:  Marta Marin-Argany; Jofre Güell-Bosch; Luis M Blancas-Mejía; Sandra Villegas; Marina Ramirez-Alvarado
Journal:  Protein Sci       Date:  2015-09-07       Impact factor: 6.725

2.  Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.

Authors:  Luis M Blancas-Mejía; Pinaki Misra; Marina Ramirez-Alvarado
Journal:  Biochemistry       Date:  2017-01-24       Impact factor: 3.162

3.  Recruitment of Light Chains by Homologous and Heterologous Fibrils Shows Distinctive Kinetic and Conformational Specificity.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Biochemistry       Date:  2016-05-16       Impact factor: 3.162

4.  Mechanistic Insights into the Early Events in the Aggregation of Immunoglobulin Light Chains.

Authors:  Pinaki Misra; Luis M Blancas-Mejia; Marina Ramirez-Alvarado
Journal:  Biochemistry       Date:  2019-07-09       Impact factor: 3.162

5.  Kinetic control in protein folding for light chain amyloidosis and the differential effects of somatic mutations.

Authors:  Luis M Blancas-Mejía; Alexander Tischer; James R Thompson; Jonathan Tai; Lin Wang; Matthew Auton; Marina Ramirez-Alvarado
Journal:  J Mol Biol       Date:  2013-10-22       Impact factor: 5.469

6.  Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans.

Authors:  Luis M Blancas-Mejía; Jared Hammernik; Marta Marin-Argany; Marina Ramirez-Alvarado
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

7.  Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.

Authors:  Kathrin Andrich; Ute Hegenbart; Christoph Kimmich; Niraja Kedia; H Robert Bergen; Stefan Schönland; Erich Wanker; Jan Bieschke
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

8.  Cell Damage in Light Chain Amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING.

Authors:  Marta Marin-Argany; Yi Lin; Pinaki Misra; Angela Williams; Jonathan S Wall; Kyle G Howell; Laura R Elsbernd; Megan McClure; Marina Ramirez-Alvarado
Journal:  J Biol Chem       Date:  2016-07-26       Impact factor: 5.157

9.  Assays for Light Chain Amyloidosis Formation and Cytotoxicity.

Authors:  Luis M Blancas-Mejia; Pinaki Misra; Christopher J Dick; Marta Marin-Argany; Keely R Redhage; Shawna A Cooper; Marina Ramirez-Alvarado
Journal:  Methods Mol Biol       Date:  2019

10.  Early events in light chain aggregation at physiological pH reveal new insights on assembly, stability, and aggregate dissociation.

Authors:  Pinaki Misra; Marina Ramirez-Alvarado
Journal:  Amyloid       Date:  2021-02-03       Impact factor: 7.141

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.